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Obesity activates a complex systemic immune
response that includes the recruitment of macro-
phages and other immune cells to key metabolic
tissues. Current models postulate that obesity and
excess lipids classically activate macrophages,
polarizing them toward an M1 (inflammatory) state.
Little is known about noninflammatory functions
of adipose tissue macrophages (ATMs). Here, we
show that the expansion of adipose tissue (AT)
across models of obesity induces a program of lyso-
some biogenesis in ATMs and is associated with lipid
catabolism but not a classic inflammatory pheno-
type. This program is induced by factors produced
by AT and is tightly coupled to lipid accumulation
by ATMs. Inhibition of ATM lysosome function im-
pairs lipid metabolism and increases lipid content
in ATMs and reduces whole AT lipolysis. These
data argue that ATMs contribute quantitatively to
the development of obesity-induced inflammation
but also serve an important role in lipid trafficking
independent of their inflammatory phenotype.
INTRODUCTION
Changes in metabolic state, including obesity, fasting, thermo-
genic challenges, weight loss, and caloric restriction, broadly
activate the immune system (Feuerer et al., 2009; Kosteli et al.,
2010; Nguyen et al., 2011; Obstfeld et al., 2010; Talukdar et al.,
2012; Weisberg et al., 2003; Winer et al., 2011; Wu et al., 2011;
Wu et al., 2007; Xu et al., 2003). In adipose tissue (AT), obesity
leads to the accumulation of macrophages to the extent that,
in the most obese individuals, as many as half of all cells in a
fat depot are macrophages (Weisberg et al., 2003). Efforts to
understand the role that AT macrophages (ATMs) play in meta-
bolism have focused largely on characterizing the inflammatory
phenotypes and functions of ATMs (Chawla et al., 2011). Indeed,
several studies have suggested that, in addition to the quantita-
tive increase in ATMs, obesity elicits a qualitative inflammatory
switch in ATM phenotypes (Lumeng et al., 2007a, b).816 Cell Metabolism 18, 816–830, December 3, 2013 ª2013 ElsevierThese studies have described that, in lean animals, alterna-
tively activated M2-like macrophages predominate, but, with
the onset of obesity, there is recruitment and accumulation of
classically activated macrophages that form multinucleated
giant cells and express CD11c and markers of M1 polarization
(Lumeng et al., 2007a, b). Most of these studies have focused
on the expression of a few genes; e.g., Tnf, Il6, Arg1, or Nos2,
or surface antigens (e.g., CD206) to categorize ATMs as M1 or
M2 (Lumeng et al., 2007a, b). However, these findings are at
odds with whole-tissue expression and other analysis of ATM
populations. For example, in whole AT, the expression of Arg1
and CD206+ cells increases in obese individuals despite the
fact that they are markers of M2 polarized cells (Bourlier et al.,
2008; Shaul et al., 2010). Nonetheless, the observation that the
treatment of non-ATMs, including bone-marrow-derived, perito-
neal, and immortalized macrophage-like cells, with saturated
fatty acids or conditionedmedium of adipocyte cell lines induces
an increase, albeit a modest increase in comparison to lipopoly-
saccharide (Lichtenstein et al., 2010; Shi et al., 2006; Suganami
et al., 2007), in M1 gene expression has lead to a model in which
excess lipids released from adipocytes during the development
of obesity drives M1 polarization (Osborn and Olefsky, 2012).
Although macrophages share common immune and repara-
tive roles and stereotypical inflammatory responses to many
stimuli, they also possess distinct tissue-specific developmental
programs, phenotypes, and functions that are regulated by their
cellular context (Pollard, 2009). In AT, macrophages develop and
differentiate in a lipid-rich environment, but the developmental
program and tissue-specific functions of ATMs, including those
related to lipid metabolism, have been largely unexplored. In
contrast, the well-studied functions of osteoclasts (multinucle-
ated bone macrophages) demonstrate that macrophages can
play critical roles in local tissue-specific metabolic functions
(Edwards and Mundy, 2011). We hypothesized that develop-
mental signals produced by AT similarly drive the differentia-
tion of ATMs and functions that are adapted to a lipid-rich
environment.
Defining the tissue-specific functions of ATMs and how those
functions are altered by obesity offers the possibility of identi-
fying pathways that are fundamental to normal and pathologic
function of AT. In an attempt to identify cellular functions of
ATMs that are regulated by adiposity, we profiled AT and purified
ATMs, finding that a program of lysosome biogenesis is acti-
vated by obesity. Surprisingly, we did not find that this programInc.
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instead, is tightly coupled to lipid content and catabolism.
Consistent with lysosomal-dependent lipid metabolism being a
developmentally regulated process, AT induces the differentia-
tion of bone marrow cells in a manner that recapitulates the
same program and suggests a developmental role for ATMs in
local lipid turnover.
RESULTS
Adiposity, Insulin Resistance, and Macrophage Content
Are Associated with a Common Program of Lysosome
Biogenesis in Whole Adipose Tissue
Macrophage content of AT is tightly correlated with systemic
adiposity and insulin sensitivity. As a first step for identifying
functions of ATMs that are activated by obesity, we asked
whether there were any functional classes of genes whose
expression in whole AT was correlated with adiposity,
insulin sensitivity, and macrophage-specific gene expression.
Using expression microarrays, we profiled the transcription of
perigonadal AT (PGAT) from a population of 22- to 24-week-
old mice that varied in adiposity and insulin sensitivity because
of differences in diet (low- and high-fat diets), gender, segrega-
tion of alleles that cause obesity (obese, Ay), and treatment
with insulin-sensitizing agents (thiazolidinedione and b-3
adrenergic agonist). We identified transcripts whose expres-
sion was correlated with body mass, fasting serum insulin con-
centration, or macrophage-specific gene expression (Pearson
correlation coefficient > 0.6). For each phenotype—body
mass, insulin sensitivity, and macrophage content—a func-
tional class analysis was performed (DAVID) (Huang et al.,
2009a, b), and classes of genes whose expression was corre-
lated with each phenotype were identified (Table S1 available
online).
We found 13 AT transcriptional programs coordinately and
positively regulated by adiposity (Table S1), four programs
regulated by insulin resistance (Table S1), and 22 associated
with a macrophage transcriptional program (Table S1). Consis-
tent with many previous analyses, inflammatory pathways
(e.g., immune cell and inflammatory response) were over-
represented among genes positively correlated with each
phenotype. Among noninflammatory functions, we found one
program, lysosomal biogenesis, that was also correlated with
each phenotype.
In a previous transcriptional profiling study, we noted in pass-
ing a preponderance of lysosomal-related transcripts among
genes associated with body mass, but we had not rigorously
analyzed the association (Weisberg et al., 2003). The statistical
analysis of a larger, more varied data set here reveals that genes
involved in all aspects of lysosome biogenesis and function are
coordinately upregulated with insulin resistance and obesity:
structural genes (Lamp2 and Laptm5), hydrolases (including
acid lipases, phosphatases, and proteases [Lipa, Acp5, and
Ctsk]), protein pumps required for lysosome acidification
(Atp6v1b2), and transport proteins (Ncp1) (Figure 1A) (Saftig
and Klumperman, 2009). The obesity-induced increase in lyso-
some gene transcription was not limited to PGAT and was
seen in subcutaneous and brown AT (BAT) as well despite the
fact that induction in BAT was less marked (Figure 1B). ObesityCell Mincreases insulin resistance and macrophage content of AT in
humans as well. Consistent with the obesity-dependent increase
observed in mice, the expression of lysosomal genes in
mesenteric AT from healthy obese human subjects was also
elevated in comparison to expression in AT from lean subjects
(Figure S1).
In whole PGAT, the obesity-induced increase in lysosomal
transcriptional was also associated with increased expression
of lysosomal proteins, including the structural lysosome protein
LAMP2 and the acid lipase LIPA (Figure 1C); an increase in
LAMP2 express was observed in subcutaneous tissue but not
BAT (Figure S1). Although all nucleated mammalian cells contain
lysosomes, the induction of lysosome protein was especially
pronounced in the stromal vascular fraction of cells (Figure 1D).
Lysosomes can be visualized as electron-dense bodies by elec-
tron microscopy (EM). Using transmission EM, we analyzed the
ultrastructure of epididymal AT from lean (C57BL/6J Lep+/+)
and obese (C57Bl/6J Lepob/ob) mice. Consistent with the tran-
scriptional activation, lysosomes were abundant in cells from
obese mice. Consistent with LAMP2 protein being induced in
the stromal vascular faction, lysosomes were most abundant in
cells that were distinct from adipocytes and contained what
appeared to be filopodia and large lipid-filled vesicles (Figures
1E–1H). In addition, lipid vesicles and lysosomeswere also asso-
ciated with mitochondria (Figure 1H).
Obesity Activate Lysosome Biogenesis in ATMs
Our transcriptional profiling of whole AT suggested that the
accumulation of ATMs in obesity and insulin-resistant states is
coupled with lysosomal biogenesis. However, the positive
associate of any transcriptional program with immune cells
and macrophages in particular may not reflect a qualitative
change in immune function but, rather, a quantitative increase
in macrophage number. Therefore, to determine whether the
lysosomal transcriptional program was activated in ATMs per
se and whether it was associated with the M1 polarization state
of ATMs, we isolated, quantified, and characterized AT immune
cells from lean (C57BL/6J Lep+/+) and obese (C57BL/6J
Lepob/ob) mice. As reported previously, the number of macro-
phages per adipocyte increased more than 10-fold, and,
although macrophages were the largest population of cells, all
other immune cell populations analyzed increased substantially
as well, including dendritic cells, T cells, B cells, granulocytes,
NK cells, and NKT cells (Figure 2A).
In mice, ATMs express (as nearly all macrophage populations
do) the antigens F4/80 (EMR1) and CD11b (ITGAM); however,
two large subpopulations of ATMs have been identified one
the basis of the expression of the integrin CD11c (ITGAX)
(Lumeng et al., 2007a, 2008). CD11c ATMs have been pro-
posed to represent resident macrophages in an M2-polarized
state. CD11c+ ATMs are thought to represent newly recruited
M1-polarized cells. We found that both classes of ATMs,
CD11c+ (F4/80+, CD11b+, CD11c+ [FBC]) and CD11c (F4/
80+, CD11b+, CD11c [FB]), increased in AT of obese
(C57BL/6J Lepob/ob) mice in comparison to lean animals
(C57BL/6J Lep+/+), although the increase in FBCwas proportion-
ally much greater (Figures 2A and 2B). Similar results were
obtained when comparing low-fat-fed lean and high-fat-fed






Figure 1. Obesity Activates a Program of Lysosome Biogenesis in Adipose Tissue
(A) PGAT expression of genes encoding lysosome structural proteins (Lamp2 and Laptm5), hydrolases (Lipa andCtss), and transport proteins (Npc andAtp6v0d2)
correlate with body mass.
(B) The expression of macrophage (Emr1 and Itgax) inflammatory (Tnf) and lysosome (Adp6v0d2, Ctss, and Lipa) genes in multiple fat depots including PGAT,
inguinal subcutaneous (SCAT), and intrascapular BAT from obese (C57BL/6J Lepob/ob) and lean (C57BL/6J Lep+/+) mice (n = 6).
(C) The expression of the lysosome protein LAMP2 and LIPA in whole PGAT.
(D and E) The expression of LAMP2 protein is strongly increased in SVCs of PGAT from obese (C57Bl/6J Lepob/ob) and lean (C57Bl/6J Lep+/+) mice; representative
western blots and quantification (n = 2). Transmission electron micrographs of PGAT from a lean (C57BL/6J Lep+/+) mouse with thin adipocytes (E, open arrows)
and few other interstitial cells or lysosomes.
(legend continued on next page)
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Obesity Induces Lysosome Biogenesis in ATMsThe large increase in ATM numbers may explain the increased
expression of many inflammatory and lysosomal genes; i.e., an
increased expression 5- to 10-fold. However, some lysosomal
genes (e.g., Atp6v0d2) were increased an order of magnitude
disproportionate to the increase in cell number, suggesting
a qualitative induction of a lysosomal program. In order to
determine whether obesity activated a program of lysosome
biogenesis coupled with inflammatory activation in either
CD11c (FB) or CD11c+ (FBC) macrophages, we used expres-
sion microarrays to generate transcription profiles of ATMs
from lean (C57BL/6J Lep+/+) and obese (C57BL/6J Lepob/ob)
mice. Profiling purified FBs and FBCs, we identified 521 tran-
scripts whose expression was differentially (nominal p < 0.01)
expressed between FBs from lean and obese mice and 1,509
genes whose expression was differentially (nominal p < 0.01)
expressed between FBCs from lean and obese mice (data not
shown).
Using the same pathway analysis employed to analyze whole
AT (DAVID), we found obesity activated four programs in both
FBs and FBCs (Table S1). Most of the programs that were coor-
dinately regulated by adiposity, by insulin resistance, and with
macrophage content in whole AT were not upregulated by
obesity in individual purified ATMs. Indeed, the only common
program that was detectably increased in whole AT and both
ATM populations of obese animals was the transcriptional pro-
gram of lysosome biogenesis. The same individual lysosomal
genes whose expression was correlated in whole AT with adi-
posity and insulin resistance were also upregulated in FBs and
FBCs from obese mice in comparison to lean mice (Figure 2C).
To assess whether the transcriptional program of lysosome
biogenesis program led to an increase lysosome content,
ATMs were isolated from lean (C57BL/6J Lep+/+) and obese
(C57BL/6J Lepob/ob) mice and stained with a fluorescent weak
amine that accumulates in late endosomes and lysosomes
(LysoTracker, Invitrogen). Consistent with the transcriptional
profile and our EMmicrographs, the fraction of ATMs containing
high levels of lysosomes as measured by LysoTracker accumu-
lation doubled from 26% ± 6.2% to 57% ± 4.3% (p < 0.005) in
obese mice (Figure 2D).
Lysosomes can also be visualized with the same fluorescent
dye in stromal vascular cells (SVCs) isolated from AT. SVCs
from lean (C57BL/6J Lep+/+) mice contained few ATMs and
few identifiable lysosomes (Figure 2E). By comparison, many
distinct lysosomal bodies were visible in SVCs from obese
mice and, consistent with the fluorescence-activated cell sorting
(FACS) analysis, themajority of lysosomeswere containedwithin
F4/80+-expressing ATMs. The LAMP2 protein, a structural
component of lysosomes, was expressed in ATMs purified
from AT of obese mice, but it was not detected in other immune
cells. Consistent with recent findings that autophagy plays a role
in adipocyte differentiation, nonimmune SVCs, which contain
preadipocytes, also express measurable amounts of LAMP2
(Figure 2F).(F and G) PGAT from obese (C57BL/6J Lepob/ob) mice revealing many intersti
lipid-filled vesicles (G, black arrows).
(H) The lipid-filled vesicles are surrounded by lysosomal-like structures (red arro
**p < 0.01, ***p < 0.005, ****p < 0.001). All values are means ± SD.
See also Table S1 and Figure S1.
Cell MObesity-Induced Lysosomes Biogenesis Is Not
Associated with M1 Polarization
Lysosome biogenesis is not known to be induced during clas-
sical activation of macrophages or a common feature of M1
polarization (Martinez et al., 2006). Previous expression profiles
had suggested that obesity polarized ATMs, and in particular
FBCs, toward an M1 state (Lumeng et al., 2007b). However,
our unbiased analysis did not find the enrichment of any immune
or inflammatory pathways in FBCs or FBs of obese animals.
Furthermore, comparing the expression of three dozen genes
whose expression is upregulated in classically activated macro-
phages (Martinez et al., 2006) did not reveal a consistent trend;
the expression of most inflammatory genes was unchanged
between FBs and FBCs and between lean and obese ATMs (Fig-
ures 3A–3C). Indeed, although some of the M1 genes were actu-
ally increased in FBs by obesity, most of the M1 genes whose
expression was altered in the ‘‘inflammatory’’ FBCs had reduced
rather than increased expression. Similarly, the expression of
genes activated in M2-polarized/alternatively activated macro-
phages was not different between ATM populations or ATMs in
lean and obese mice (Figures S3A–S3C). This lack of classical
activation was not specific to leptin deficiency; HFD-induced
obesity also did not activate classic inflammatory gene expres-
sion in ATMs but did induce the lysosomal gene expression
(Figures S3E and S3F).
TNFa production is a canonical marker of classically activated,
M1-polarized macrophages, and its expression is increased in
whole AT from obese animals (Figure 3D) (Gordon and Martinez,
2010). Though modest in comparison to classic activation
induced in macrophages by LPS, we found, in addition to an
increase in Tnf gene expression, an increase in expression of
TNFa protein in total SVCs from obese (C57BL/6J Lepob/ob)
mice. However, no measurable increase in TNFa among purified
ATMs was detectable from obese mice in comparison to lean
mice (C57BL/6J Lep+/+) (Figure 3E) by western blot. Using
FACS analysis, we found that a small fraction of ATMs isolated
from AT of obese mice (both FBs and FBCs) expresses detect-
able amounts of TNFa and Il-1b, but, in comparison to spleno-
cytes isolated from LPS-injected mice, the expression of both
classic inflammatory proteins as assessed by mean fluores-
cence intensity (MFI) was an order of magnitude lower in ATMs
(Figure 3H). The only obesity-dependent effect we could detect
was an increased shoulder in TNFa expression in FBCs associ-
ated with a large increase in total FBCs. Similarly, when we
sought to use the surface antigenmarker CD206 (MRC1) to iden-
tify M2-polarized/ alternatively activated ATMs, we found that
obesity did not reduce, but actually increased, the fraction of
CD206+ among immune cells, including FBCs (Figures 3F and
3G). Altogether, these data argue that obesity does not induce
a simple classic binary switch in ATMs toward to an M1-
polarized state. Instead, although some inflammatory genes
are induced, others are reduced, and the M1/M2 paradigm
does not neatly describe the effect of obesity on ATMs. Thesetial nonadipocyte cells. At higher magnification, these nonadipocyte contain
ws) and mitochondria (blue arrows) in nonadipocyte cells (outlines) (*p < 0.05,






(legend on next page)
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of whole AT are attributable largely to quantitative changes in
immune cells rather than a binary switch.
Lipid Droplet Accumulation Is Associated with ATM
Lysosome Biogenesis
Lysosomes servemultiple functions in macrophage populations,
including the processing of antigens for presentation, pathogen
destruction, bone resorption, degradation of products of auto-
phagy, and reverse cholesterol trafficking (Saftig and Klumper-
man, 2009). Recent studies suggest that lipid droplets are
metabolized in a lysosomal-dependent autophagy pathway in
nonadipocytes (Ouimet et al., 2011; Singh and Cuervo, 2012;
Singh et al., 2009a,b; Zhang et al., 2009). Obesity and insulin
resistance increase neutral lipid content in ATMs, though it is
not known whether CD11c+ or CD11c differentially accumu-
late lipid. Our expression, protein, and histological data suggest
that both FB and FBC upregulate lysosome biogenesis; how-
ever, FBCs increase this program more than FBs (Figures 2C
andS3). To investigate whether FBCs thatmore strongly upregu-
late the lysosome biogenesis program also accumulate lipid, we
isolated CD11c (FB) and CD11c+ (FBC) ATMs from SVCs of
lean (C57BL/6J Lep+/+) and obese leptin-deficient (C57BL/6J
Lepob/ob) mice. If the accumulation of neutral lipid regulates lyso-
somes biogenesis in ATMs, then we predicted that FBCs from
obese mice would contain more lipid than FBs. Indeed, FBCs
from obese animals contain larger and more numerous lipid
droplets than FBCs from lean animals or even FBs from obese
mice (Figures 4A and 4B).
After the digestion of AT from obese mice, a large number of
buoyant ATMs are found floating in the ‘‘adipocyte’’ fraction
(Weisberg et al., 2003). We reasoned that ATMs in the adipo-
cyte fraction would contain the largest amount of lipid and
provide an opportunity to visualize the cellular relationship be-
tween lysosomes and lipid droplets. We digested and sepa-
rated AT of obese (C57BL/6J Lepob/ob) and lean mice into
buoyant and pelleted fractions. Using fluorescence confocal
microscopy, we found virtually no ATMs in the buoyant samples
from lean mice (data not shown) but many lipid-laden F4/80+
ATMs in the buoyant samples from obese animals. We found
two classes of spherical acidic structures containing lipid: one
class of these structures possessed a central core of lipid sur-
rounded by an acidic ring, and in the second, typically smaller
structures, the lipid and lysosome markers overlapped (Figures
4C and 4D).Figure 2. Obesity Activities Lysosome Biogenesis in ATMs
(A) Quantification of individual immune cell populations, including CD11c (FB)
T cells, NK cells (NK), NKT cells (NKT), and B cells in PGAT from lean (C57BL/6
(n = 5–6).
(B) FBC and FB macrophages were purified from lean and obese PGAT with FAC
(C) The expression of lysosome genes was increased in both CD11c (FBs) and
(D) Lysosome content asmeasured by a fluorescent amine (LysoTracker) that acc
obese mice but not other immune cells (F); representative FACS and quantifica
(E)With the use of immunofluorescence staining of SVCs to identify nuclei (Sytox,
that most ATMs from obese mice contain visible lysosomes. Lysosomes were als
40 mm).
(F) The expression of LAMP2 protein in ATMs (F4/80+), nonmacrophage immune
Lepob/ob) mice (n = 4; *p < 0.05, **p < 0.01, ***p < 0.005). All values are means ±
See also Figure S2.
Cell MTo confirm and quantify that lipid droplets of ATMs from obese
mice are associated with lysosome content, we used FACS to
simultaneously quantify lipid and lysosome content among all
ATMs. There was broad variation in neutral lipid and lysosome
content, but, consistent with lipid droplet being tightly linked
with lysosome biogenesis, the accumulation of the lysosome
marker (LysoTracker) was linked with lipid accumulation
(BODIPY) and most strongly with FBCs. The fraction of FBCs
that were BODIPY+ and LysoTracker+ increased from 26% to
more than 86% (Figure 4E).
Adipose Tissue Induces Lysosome Biogenesis, but Not
Inflammatory Polarization, of Macrophages
Previous studies had found that saturated fatty acids and
conditionedmedium from adipocyte cell lines classically activate
differentiated bone-marrow-derived and peritoneal macro-
phages, supporting amodel of obesity-induced fatty acid activa-
tion of ATMs (Lichtenstein et al., 2010; Shi et al., 2006; Suganami
et al., 2007). However, our data suggest that the developmental
program of ATMsmay elicit a different response to excess lipids,
one in which lysosome biogenesis is a key phenotype. To test
whether AT induces the development of macrophages that
activate lysosome biogenesis, we differentiated bone marrow
cells with a protocol similar to standard osteoclast differentiation
methods but substituted AT for primary osteoblasts (Figure 5A).
In the presence of M-CSF/CSF-1 alone, bone marrow cells
efficiently differentiated into cells that possess characteristics
typical of macrophages: adherent mononuclear cells with a
high cytoplasm/nuclear ratio and high F4/80+ and low CD11c+
expression (Figure 5B). However, when cells were differentiated
in the presence of AT, they took on characteristics observed in
primary ATMs: intermediate F4/80 expression, high expression
of CD11c (ITGAX), the appearance of multinucleated cells, the
accumulation of neutral lipids (Figures 5B and 5C), and the in-
duction of genes that are enriched in ATMs in comparison to
other tissue myeloid cells (e.g., Cxcl1 and Tnfs9) (Figure S4).
Consistent with our expression studies of primary ATMs, the
differentiation of macrophages in the presence of AT did not
induce the expression of a consistent M1 polarization program,
no change occurring in the expression of Tnf, Tlr2, Tlr4, and
Il10 (Figure 5D), and an increase in the expression of both M2-
and M1-associated genes, including Arg1, Il1b, and Nos2
(Figure 5D).
Although differentiation in the presence of AT did not consis-
tently induce inflammatory gene expression, it did stronglyand CD11c+ (FBC) macrophages, dendritic cells (DCs), granulocytes (Gran),
J Lep+/+) and obese (C57BL/6J Lepob/ob) PGAT SVCs as measured by FACS
S and profiled with expression microarrays.
CD11c+ (FBCs) from obese mice in comparison to lean mice (n = 4).
umulates in acidic cellular compartments is increased in F4/80+ ATMs (F+) from
tion (n = 5).
green), macrophages (F4/80+, blue) and lysosomes (LysoTracker, red) revealed
o visible in a population of non-ATM SVCs from obese mice (calibration mark =
cells (CD45+, F4/80), and nonimmune SVCs from PGAT of obese (C57BL/6J
SD.








Figure 3. Obesity Does Not Classically Activate or M1 Polarize ATMs
The expression of genes activated by M1 polarization of macrophages in (A) lean (C57BL/6J Lep+/+) and obese (C57BL/6J Lepob/ob) CD11c (FB) or (B) CD11c+
(FBC) macrophages.
(C) Relative expression of M1 polarization genes in FBs from FBCs from lean mice (n = 5).
(legend continued on next page)
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Obesity Induces Lysosome Biogenesis in ATMsupregulate the expression of genes involved in lipid uptake and
storage, including the scavenger receptor Msr1 and lipid-
droplet-associated protein Plin2 (Figure 5D). AT also induced
the expression of lysosome genes activated in ATMs by obesity,
including Atp6v0d2, Lipa, and Ctsk. Consistent with these tran-
scriptional phenotypes, macrophages that underwent terminal
differentiation in our protocol accumulated neutral lipid and con-
tained numerous lysosomes, whereas macrophages differenti-
ated with only M-CSF/CSF-1 had scant lipid and few lysosomes
(Figures 5E and 5F). These data suggest that secreted factors,
including lipids, produced by AT do not classically activate
ATMs per se but induce a differentiation program in which lipid
uptake and lysosomal biogenesis are coordinately regulated.
Lysosomal-Dependent Metabolism of Lipids in ATMs
and Adipose Tissue
In both primary and in vitro differentiated ATMs lipid, droplets
and lysosomes colocalize, suggesting that lysosomes may
also play a role in lipid metabolism. A class of antimalarial drugs,
including chloroquine, is lysosomotrophic and inhibits the acidi-
fication of lysosomes and acid-dependent lipase activity. If lyso-
somes function is necessary for lipid catabolism in ATMs, then
inhibition by chloroquine should lead to the accumulation of lipid
droplets. To test this directly, ATMs were differentiated in vitro
with the protocol developed above and treated with chloroquine
for 16 hr. As expected, treatment reduced detectable lysosomes
in bone-marrow-derived ATMs (Figure 6C) and, as a compensa-
tory response, increased the expression of lysosome genes,
including Atp6v0d2, Lipa, and Ctsk (Figure 6A). Consistent with
a role for lysosomes in lipid catabolism in ATMs, inhibiting lyso-
some function increased the lipid content markedly (Figures 6B
and 6C). The accumulation of lipids in chloroquine treated
ATMs without a clear inflammatory activation argue that lipids
do not have an inherent inflammatory effect on ATMs (Figure 6A).
A second inhibitor of lysosomal function had the same effect.
Bafilomycin A1 prevents multiple steps in endocytic trafficking
and lysosomal hydroplyses by inhibiting H+ATPases required
for lysosomal acidification. Treating ATMs with bafilomycin A1
also reduced lysosomes and increased lipid content of ATMs
(Figure S5).
Recent studies have found that lipid homeostasis in hepato-
cytes, adipocytes, and foam cells occurs in part through a
lysosomal-dependent autophagy pathway, dubbed lipophagy
(Ouimet et al., 2011; Singh and Cuervo, 2012; Singh et al.,
2009a, b; Zhang et al., 2009). The inhibition of autophagy in
hepatocytes and foam cells through target deletion of critical
autophagy genes increased the lipid content of cells. However,
when we generated ATMs that lacked the Atg7 necessary for
normal autophagy, we found no increase in the lipid content of(D) Expression of Tnf, the prototypical M1 activation gene, in whole PGAT, ATMs
(E) TNFa protein protein expression in whole SVCs and purified ATMs from obese
a positive control.
(F) Typical FACS plot of SVCs expressing the M2-marker CD206 and (G) increas
either the fraction of all immune CD45.2+ or fraction of ATMs.
(H) Typical FACS histograms of FBs, FBCs or all ATMs stained for TNFa. The b
with LPS.
(I) Typical FACS histograms of FBs, FBCs or all ATMs stained for IL1b (n = 4). The
with LPS (*p < 0.05, **p < 0.01, ***p < 0.005). All values are means ± SD.
See also Figure S3.
Cell MATMs, arguing against autophagy being required for lysosomal
degradation of lipids (Figure S5).
Reports dating back to the 1960s have demonstrated that
chloroquine treatment acutely reduces AT lipolysis and improves
systemic glucose and lipid homeostasis (Benoit, 1967; Powrie
et al., 1993, 1991). It has been hypothesized that the systemic
effect of chloroquine in reducing circulating lipids concentrations
was secondary to increased circulating insulin concentrations
due to reduced lysosomal-dependent hepatic clearance. To
determine whether chloroquine could directly act on AT to
reduce lipolysis in an ATM-dependent manner, we treated pri-
mary AT cultures with chloroquine. We compared the effect of
chloroquine on lipolysis from AT of lean and obese mice. As
would be predicted if chloroquine-induced reduction in lipolysis
was ATM-dependent, treatment of ATM-poor AT from lean mice
had no consistent effect on lipolysis, as measured by the release
of nonesterified fatty acids or glycerol. In contrast, chloroquine
treatment of AT from obese mice reduced lipolysis by 20%
(Figures 7A and 7B). ATMs are efficiently depleted from AT
ex vivo by liposome-encapsulated clodronate. If ATM lysosomal
function is critical for chloroquine’s suppression of lipolysis by
AT, then the depletion of ATMs should eliminate any chloroquine
effects. Indeed, chloroquine did not reduce lipolysis in AT
depleted of macrophages (Figure S6).
Although previous studies suggested that chloroquine’s ability
to improve metabolic phenotypes in patients with diabetes is
secondary to increased plasma insulin concentration our data
argue that there may also be direct effects on AT lipid trafficking.
Using obese (C57BL/6J Lepob/ob) mice, we tested whether the
direct delivery of chloroquine into AT would reduce lipolysis
without increasing circulating insulin. Injection of chloroquine
directly into visceral AT depots of obesemice lowered circulating
nonesterified fatty acid concentrations within 24 hr. However,
therewas no effect of local chloroquine injection on serum insulin
(Figures 7C and 7D). Altogether, the ex vivo and in vivo data
argue that the acute effects of chloroquine are mediated, at least
in part, by the local action of chloroquine in impairing lysosome
function of ATMs in addition to any effects on increasing plasma
insulin concentrations.
DISCUSSION
Studies aimed at understanding the role of the immune system in
obesity and associated disorders have focused largely on quan-
titative changes in immune cell populations and classic inflam-
matory responses; the effect of adiposity on no-inflammatory
functions has been less well studied. However, in other tissues,
macrophages serve developmentally specific functions critical
to organ function, including ovulation, steroid hormone(F4/80+), and subpopulations of FBs and FBCs from lean and obese mice.
mice in comparison to leanmice. The last lane contains purified TNFa (10 pg) as
ed numbers of CD206+ ATMs in PGAT from obese compared to lean mice as
eige curve represents data from splenocytes isolated from a mouse injected
beige curve represents data from splenocytes isolated from a mouse injected





Figure 4. Lysosomes Accumulate in Lipid-Laden ATMs
(A andB) Purified FB (CD11c) and FBC (CD11c+) ATMs from lean (C57BL/6J Lep+/+) and obese (C57BL/6J Lepob/ob) mice stainedwith hematoxylin (A) or Oil Red
O (B) in order to reveal morphology and lipid content, respectively.
(C) Immunofluorescent confocal images of buoyant ATMs (copurify with adipocytes) isolated from the AT of obese mice and containing large lipid vesicles.
(D) Immunofluorescent confocal images of a live nonbuoyant ATM (with classic SVCs) containing smaller lipid vesicles. Lipid-laden ATMs expressing the
macrophage specific antigen F4/80 (blue) and containing lipid (green) vesicles and lysosomes (red). White arrowheads identify large lipid-containing vesicles, red
arrows indicate lysosomes, white arrows indicate lipid vesicles with acidic rings, and yellow arrows indicate colocalization of lysosome and lipid staining.
Calibration mark = 10 mm.
(E) Lipid and lysosome content of macrophages (F/80+ cells) and FBCs from lean and obese mice were quantified by FACS (n = 5; **p < 0.01). All values are
means ± SD.
See also Figure S4.
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Figure 5. Adipose Tissue Induces an ATM Phenotype without Inflammation
(A) Cartoon of ATM differentiation protocol with timeline of bone marrow cells cultured with M-CSF (CSF-1) in the absence or presence of AT.
(B) F4/80+ and CD11c+ populations identified by FACS among bone marrow cells differentiated in the absence of both M-CSF and AT in the presence of M-CSF
only or in the presence of both M-CSF and AT.
(C) Hematoxylin and Oil Red O staining for lipid of bone marrow cells differentiated with M-CSF in the absence or presence of AT.
(D) Inconsistent induction of inflammatory gene expression when bone marrow cells are differentiated in the presence of AT; activation of lipid metabolism and
lysosome genes by AT-induced differentiation (n = 5).
(legend continued on next page)
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AB
C
Figure 6. Inhibition of Lysosome Function Increases Lipid Accumulation in ATMs
(A) The expression of macrophage-related, lysosome and lipid metabolism genes in AT induced in ATM-like cells in the presence or absence of chloroquine.
(n = 6; *p < 0.05, **p < 0.01, ***p < 0.005).
(B and C) Immunofluorescent confocal images of lysosomes and lipid among in vitro differentiated ATMs (B) and ATMs treated with chloroquine (C). Nuclei were
identified with DAPI, macrophages (Mac) with an anti-F4/80, lysosomes with LT, neutral lipid with Bodipy. All values are means ± SD.
See also Figure S6.
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2009). Our efforts to identify noninflammatory functions of the
immune system elicited by obesity have revealed that ATMs,
the dominant immune cell in AT, respond to increases in
adiposity by activating a program of lysosomal metabolism of
lipids. This lysosomal program is partly under the developmental
control of factors secreted from AT and closely coupled to lipid
accumulation. The inhibition of lysosomal function increases
lipid accumulation in ATMs and reduces the release of nonester-
ified fatty acids from AT. The net effect of ATMs is to buffer
increased concentrations of lipids (Figure 7). Surprisingly, we
found that obesity elicited no consistent polarization of ATMs to-
ward a classically activated state, arguing that the increase in the
inflammatory profile of AT associated with obesity derives pri-
marily from quantitative increases in immune cell populations.
These observations suggest that the pathway of lipid release
by AT is not simply a two-step process of hydrolysis of trigly-
ceride (TG) in adipocytes and release of nonesterified fatty
acid (NEFA) into the circulation, nor is the trafficking of lipids
the same in lean and obese AT. Instead, the pathway appears(E) Immunofluorescent staining of bone marrow cells differentiated in the absence
lysosomes (LysoTracker [LT], red), and neutral lipid (Bodipy, green). Calibration m
(F) High magnification of immunofluorescent stained confocal images. Calibration
See also Figure S5.
826 Cell Metabolism 18, 816–830, December 3, 2013 ª2013 Elsevierto change with increasing adiposity; in AT with large adipocytes,
released lipid is taken up by macrophages and targeted to lyso-
somes for metabolism. By either direct stoichiometric effects on
lipid release or, more likely, through the indirect action of factors
that reduce release of lipids by adipocytes, the inhibition of lyso-
somes and increased lipid accumulation in ATMs has the effect
of reducing NEFA release by AT and buffering other cells from
any toxic effects of excess lipids.
Because perturbations in the efficiency of lipid storage and
trafficking by AT are central to the development of metabolic dis-
eases, the role of ATM lysosome function may provide insights
and potential therapeutic targets for understanding and treating
obesity-related diabetes, hepatic steatosis, and cardiovascular
disease. Any attempts to target ATM lysosome pathway to
modulate AT metabolism, though, will require further elucidation
of the uptake of lipid by ATMs, the signaling effects of lipid
sensing and accumulation by ATMs, the ultimate fate of lyso-
somal products of lipid hydrolysis, and the anabolic factors
elaborated by ATMs. Some clues may be gleaned from previous
published observations and our data here.or presence of AT to identify nuclei (DAPI, silver), macrophages (F4/80+, blue),
ark = 50 mm.






Figure 7. Lysosome Function Modulates Lipolysis in Macrophage-Rich Adipose Tissue
(A) Expression of macrophage and lysosome genes from PGAT of lean (C57BL/6J Lep+/+) and obese (C57BL/6J Lepob/ob) mice treated ex vivo with chloroquine.
(B) The effect of lysosome inhibition by chloroquine on the release of free fatty acids and glycerol from PGAT of lean and obese mice.
(legend continued on next page)
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Obesity Induces Lysosome Biogenesis in ATMsIn ATMs that contain the largest amount of lipid, there appear
to be vesicles of at least two types. Both classes of lipid
vesicles aggregate at the periphery of the cell near the plasma
membrane. One population contains only neutral lipid, whereas
the second has an acidic ring. One plausible explanation is
that the neutral lipid vesicles fuse with primary lysosome forming
an acidic-ringed secondary lysosome. In cells containing fewer
lipids, there appears to be a single class of lipid containing
vesicles that are acidic. If neutral lipid vesicles fuse with a lyso-
some, then it would imply that the neutral lipid vesicles are not
classic lipid droplet but rather membrane vesicles, raising the
possibility that the lipid is derived through an endocytic-
phagocytic pathway. The phagocytosis of large lipid droplets
may derive from dead or dying adipocytes or alternatively
through some regulated process; e.g., the exocytosis of
TG droplets or macrophage-adipocyte transfer. However, in
addition to a pathway of TG uptake, we found transcriptional
evidence for fatty acid uptake and esterification by ATMs.
ATMs from obese animals upregulate the expression of fatty
acid transporters, Msr1, Cd36, and esterification enzyme
Dgat2 (data not shown). Given the ability of macrophages to
broadly scavenge molecules through different pathways, it
seems likely that multiple forms are taken up into lipid vesicles.
The fate of the lipid after it fuses with the primary lysosome is
also not clear. Inhibition studies with chloroquine imply hydroly-
sis of neutral lipid into fatty acids and glycerol. If the ATMs func-
tion to buffer excess lipids, then it would make sense that a
portion of the lipid is oxidized. Unlike the reduction in the expres-
sion of mitochondrial and peroxisomal-specific genes that
occurs in adipocytes with the onset of obesity, the expression
of several genes involved in medium- and long-chain fatty acid
oxidation are upregulated in ATMs from obese mice. Alterna-
tively, there may exist a complex recycling system in which
FFAs are released by ATMs and either resterified by adipocytes
or released into the circulation.
The reduction in AT lipolysis and plasma concentrations of
nonesterified fatty acids induced by chloroquine and other lyso-
somotrophic agents has been known for several decades and
attributed to enhanced insulin signaling. Our data suggest that,
at least in the short-term, chloroquine reduces lipid metabolism
via its effects on ATMs. These data argue that either a substantial
fraction of the NEFA released from AT of obese individuals is
released by ATMs or inhibition of lysosomes and lipid accumula-
tion in ATMs secondarily suppresses adipocyte lipolysis via the
release of antilipolytic factors. In the first model, long-term
manipulation of ATMs’ lysosomal function would have minimal
effect and may prove detrimental. Alternatively, if ATMs sense
lipid accumulation and activate lysosomes and secrete anabolic
factors to reduce their lipid load, thenmodulating ATM lysosome(C) Macrophage, lysosome, and lipid metabolism genes in PGAT 24 hr after injec
(D) Circulating concentrations of free fatty acids, glycerol, and insulin 24 hr after in
0.01, ***p < 0.005). All values are means ± SD.
(E) During the development of obesity, adipocytes undergo hypertrophy and apop
and TGs. Excess lipids are recognized by the immune system and increase the ac
cells from lipotoxic effects. Once in ATMs, the lipids are directed to lysosomal p
release of NEFAs by AT is increased. Conversely, short-term inhibition of lysosom
Inhibition of lysosomesmay reduce lipolysis through direct stoichiometric effects o
increases in ATMs.
828 Cell Metabolism 18, 816–830, December 3, 2013 ª2013 Elsevierfunction may afford indirect means of modulating adipocyte
function. Unfortunately, the current studies do not distinguish
between these actions but provide additional evidence that
ATMs modulate lipid flux out of AT. Nonetheless, if the action
of ATMs on lipid trafficking are mediated primarily via secreted
factors, then our data would argue that increasing lipid content
in ATMs favors the production of such anabolic and antilipolytic
factors. Efforts are underway to identify such factors and define
their regulation by lipid content.
Previous studies have argued that obesity polarizes the largest
immune cell population, ATMs, toward a classically activated
state. A model has emerged in which saturated free fatty acids
released in proportion to adiposity activate pattern recognition
receptors to recruit and activate a population of CD11c+
ATMs, increasing the local production of inflammatory mole-
cules by increasing both the number of ATMs and the amount
produced by individual cells. We did not observe an obesity-
driven phenotypic switch of macrophages from an M2/anti-
inflammatory to an M1/inflammatory state; there was no
consistent obesity-induced increase in the expression of genes
associated with M1 polarization in either CD11c+ or CD11c
ATMs, nor did we find that CD11c+ in comparison to CD11c
ATMswere simply moreM1 polarized. These data are consistent
with the observation that the obesity-induced increase in AT
expression of prototypical inflammatory molecules including
TNFa is commensurate with the increase in the number of
macrophages and other immune cells; i.e., an order of magni-
tude increase in macrophage content occurs with a 10-fold
increase in Tnf expression.
These findings do not imply that the expression of classical
inflammatory molecules by ATMs is without metabolic conse-
quences; a large amount of data suggest that, at least in rodents,
genetic and pharmacologic manipulations that increase the
expression of inflammatory molecules by ATMs impair the meta-
bolic function of AT, and, conversely, reducing the inflammatory
profile of ATMs reduces metabolic derangements associated
with obesity. Instead, our data argue the degree to whichmacro-
phage-derived inflammatory cytokines increase the overall
inflammatory profile and modulate AT metabolism is dominated
by quantitative increases in cell numbers rather than qualitative
changes in the classically defined inflammatory state. These
data also do not preclude that obesity induces changes in the
inflammatory state of subpopulations of macrophages, but
they do argue that, in the aggregate, there is no polarization
toward a traditionally defined M1 state or away from a traditional
M2 state in obese rodents. In addition, although obesity did not
induce changes in expression that recapitulated classical or
alternative activation, there were consistent changes in a large
number of immune regulatory genes, including obesity-inducedtion of either PBS or chloroquine.
jection of PBS or chloroquine into PGAT of obese mice (n = 5–6; *p < 0.05, **p <
tosis, leading to increases in the local concentrations of lipids, including NEFAs
cumulation of ATMs. By uptaking extracellular lipids, ATMs buffer surrounding
athway of catabolism. In the absence of ATMs after clodronate treatment, the
al catabolism increases lipid content of ATMs and reduces net lipolysis of AT.
n lipid fluxes or via increased production of antilipolytic factors as lipid content
Inc.
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Obesity Induces Lysosome Biogenesis in ATMsreduction in Il6 and chemokinesCxcl11 andCcl19. Thus, obesity
alters the expression of immune regulatory genes but does
so in amanner distinct from previously described classes of acti-
vation. How this distinct pattern of inflammatory gene expres-
sion affects metabolic function remains to be determined.
The unexpected lack of M1 polarization and the atypical tran-
scriptional profile of ATMs from obese mice despite high local
concentration of NEFA suggested that ATMs possess a develop-
mental program and response to lipids distinct from other
macrophage populations. Indeed, in vitro differentiation studies
suggest that the response of ATMs to high concentrations of
lipids and free fatty acids is distinct from typically differentiated
bone marrow macrophages. The differentiation of cells in the
presence of AT not only induced phenotypes characteristic of
ATMs, including being multinucleated and expressing CD11c,
and the coupled accumulation of lipids and lysosomes but also
did not polarize the macrophages in a classical or M1 state.
Perhaps, in retrospect, this should not be entirely unexpected;
these findings reinforce the model of tissue macrophages as a
group of cells that share common progenitors and immunologic
characteristics but also possess distinct noninflammatory,
trophic functions that are developmentally regulated by cellular
context.
EXPERIMENTAL PROCEDURES
Animals and Animal Care
Mice were obtained from the Jackson Laboratory or fromMasaaki Komatsu at
Tokyo Metropolitan Institute of Medical Science (Komatsu et al., 2006). All
procedures were approved by the Columbia University International Animal
Care and Use Committee.
Isolation and Culturing of Primary Cells
AT or bone marrow were isolated with standard techniques from mice
immediately after CO2 asphyxiation. Bone marrow cells were differentiated
into ATM-like cells by coculturing nonadherent cells in the presence of
whole PGAT.
Quantitative RT-PCR
Total RNA was extracted from tissues with either an acid-phenol- or silica-
membrane-based methods. Complementary DNAs were generated with a
commercially available kit, and quantitative PCR was carried out with fluores-
cent double-stranded DNA dye. Data were normalized to Ppib with the DDC(t)
method and are presented as relative transcript levels. All primers used are
listed in Table S2.
Immunophenotyping and Flow Cytometry
For standard FACS analysis, cells were collected in FACS buffer and
incubated with blocking FcBlock (BD Pharmingen) antibody and with fluoro-
phore-conjugated antibodies or fluorescent dyes.
Microarray Gene Expression
For whole AT samples, total RNA was extracted from the PGAT of individual
mice. RNAwas isolated from sorted FBC (F4/80+, CD11b+, and CD11c+) cells
and FB (F4/80+, CD11b+, and CD11c) cells with RNeasy micro kits (Qiagen)
with a PicoPure RNA isolation kit and amplified for two rounds. Functional
class analysis was performed with DAVID Suite software (NIAID, NIH http://
david.abcc.ncifcrf.gov).
Western Blot
Purified SVCs, adipocyte-rich fractions, and whole AT samples were
subjected to denaturing gel electrophoresis and standard western blotting
techniques.Cell MMacrophage Depletion and Lysosome Inhibition
Macrophage depletion was carried out with liposomes containing clodronate
as previously described (Kosteli et al., 2010). Lysosomes function was
inhibited in vitro with either chloroquine or bafilomycin a1 and in vivo with
chloroquine.
Electron Microscopy
Transmission electron microscopy was performed on AT taken from mice
perfused with fixative according to standard protocols.
Human Adipose Tissue
AT was collected from twenty obese (body mass index ranging from
34.8–61.3 kg/m2) Caucasian women with a mean age of 40.5 (26–50) years
old who were scheduled for Roux-en-Y gastric bypass surgery were included.
The study was approved by the Medical Ethical Committee of the Academic
Medical Center, Amsterdam.
Statistics
Data are presented as mean ± SD. All p values were calculated with a
two-tailed distribution, two-sample unequal variance Student’s t test. All
calculations were performed with Microsoft Excel and Statistica.
ACCESSION NUMBERS
RNA isolate data were deposited in NCBI Gene Expression Omnibus under
accession number GSE8831.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2013.11.001.
ACKNOWLEDGMENTS
We thank Rudy Leibel, Ira Goldberg, and Domenico Accili for insightful com-
ments and suggestions. We are grateful to Masaaki Komatsu for providing
mice. These studies were supported by research and center grants from the
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK;
DK066525, DK063608, and DK026687) and the Russell Berrie Foundation.
A.G. was support by a fellowship grant from the NIDDK (DK007647).
Received: February 15, 2013
Revised: September 3, 2013
Accepted: October 15, 2013
Published: December 3, 2013
REFERENCES
Benoit, F.L. (1967). The inhibitory effect of chloroquine on rat adipose tissue
metabolism in vitro. Metabolism 16, 557–561.
Bourlier, V., Zakaroff-Girard, A., Miranville, A., De Barros, S., Maumus, M.,
Sengenes, C., Galitzky, J., Lafontan, M., Karpe, F., Frayn, K.N., and
Bouloumie´, A. (2008). Remodeling phenotype of human subcutaneous
adipose tissue macrophages. Circulation 117, 806–815.
Chawla, A., Nguyen, K.D., and Goh, Y.P. (2011). Macrophage-mediated
inflammation in metabolic disease. Nat. Rev. Immunol. 11, 738–749.
Edwards, J.R., and Mundy, G.R. (2011). Advances in osteoclast biology: old
findings and new insights frommousemodels. Nat Rev Rheumatol 7, 235–243.
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J.,
Goldfine, A.B., Benoist, C., Shoelson, S., and Mathis, D. (2009). Lean, but
not obese, fat is enriched for a unique population of regulatory T cells that
affect metabolic parameters. Nat. Med. 15, 930–939.
Gordon, S., and Martinez, F.O. (2010). Alternative activation of macrophages:
mechanism and functions. Immunity 32, 593–604.etabolism 18, 816–830, December 3, 2013 ª2013 Elsevier Inc. 829
Cell Metabolism
Obesity Induces Lysosome Biogenesis in ATMsHuang, W., Sherman, B.T., and Lempicki, R.A. (2009a). Bioinformatics enrich-
ment tools: paths toward the comprehensive functional analysis of large gene
lists. Nucleic Acids Res. 37, 1–13.
Huang, W., Sherman, B.T., and Lempicki, R.A. (2009b). Systematic and inte-
grative analysis of large gene lists using DAVID bioinformatics resources.
Nat. Protoc. 4, 44–57.
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T.,
Koike, M., Uchiyama, Y., Kominami, E., and Tanaka, K. (2006). Loss of auto-
phagy in the central nervous system causes neurodegeneration in mice.
Nature 441, 880–884.
Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J.F., Lei, J., Zechner, R., and
Ferrante, A.W., Jr. (2010). Weight loss and lipolysis promote a dynamic
immune response in murine adipose tissue. J. Clin. Invest. 120, 3466–3479.
Lichtenstein, L., Mattijssen, F., de Wit, N.J., Georgiadi, A., Hooiveld, G.J., van
der Meer, R., He, Y., Qi, L., Ko¨ster, A., Tamsma, J.T., et al. (2010). Angptl4
protects against severe proinflammatory effects of saturated fat by inhibiting
fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 12,
580–592.
Lumeng, C.N., Bodzin, J.L., and Saltiel, A.R. (2007a). Obesity induces a
phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest.
117, 175–184.
Lumeng, C.N., Deyoung, S.M., Bodzin, J.L., and Saltiel, A.R. (2007b).
Increased inflammatory properties of adipose tissue macrophages recruited
during diet-induced obesity. Diabetes 56, 16–23.
Lumeng, C.N., DelProposto, J.B., Westcott, D.J., and Saltiel, A.R. (2008).
Phenotypic switching of adipose tissue macrophages with obesity is gener-
ated by spatiotemporal differences in macrophage subtypes. Diabetes 57,
3239–3246.
Martinez, F.O., Gordon, S., Locati, M., and Mantovani, A. (2006).
Transcriptional profiling of the human monocyte-to-macrophage differentia-
tion and polarization: new molecules and patterns of gene expression.
J. Immunol. 177, 7303–7311.
Nguyen, K.D., Qiu, Y., Cui, X., Goh, Y.P., Mwangi, J., David, T., Mukundan, L.,
Brombacher, F., Locksley, R.M., and Chawla, A. (2011). Alternatively activated
macrophages produce catecholamines to sustain adaptive thermogenesis.
Nature 480, 104–108.
Obstfeld, A.E., Sugaru, E., Thearle, M., Francisco, A.M., Gayet, C., Ginsberg,
H.N., Ables, E.V., and Ferrante, A.W., Jr. (2010). C-C chemokine receptor 2
(CCR2) regulates the hepatic recruitment of myeloid cells that promote
obesity-induced hepatic steatosis. Diabetes 59, 916–925.
Osborn, O., and Olefsky, J.M. (2012). The cellular and signaling networks link-
ing the immune system and metabolism in disease. Nat. Med. 18, 363–374.
Ouimet, M., Franklin, V., Mak, E., Liao, X., Tabas, I., and Marcel, Y.L. (2011).
Autophagy regulates cholesterol efflux from macrophage foam cells via lyso-
somal acid lipase. Cell Metab. 13, 655–667.
Pollard, J.W. (2009). Trophic macrophages in development and disease. Nat.
Rev. Immunol. 9, 259–270.
Powrie, J.K., Smith, G.D., Shojaee-Moradie, F., So¨nksen, P.H., and Jones,
R.H. (1991). Mode of action of chloroquine in patients with non-insulin-depen-
dent diabetes mellitus. Am. J. Physiol. 260, E897–E904.830 Cell Metabolism 18, 816–830, December 3, 2013 ª2013 ElsevierPowrie, J.K., Shojaee-Moradie, F., Watts, G.F., Smith, G.D., So¨nksen, P.H.,
and Jones, R.H. (1993). Effects of chloroquine on the dyslipidemia of non-
insulin-dependent diabetes mellitus. Metabolism 42, 415–419.
Saftig, P., and Klumperman, J. (2009). Lysosome biogenesis and lysosomal
membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10,
623–635.
Shaul, M.E., Bennett, G., Strissel, K.J., Greenberg, A.S., andObin, M.S. (2010).
Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macro-
phages during high-fat diet—induced obesity in mice. Diabetes 59, 1171–
1181.
Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., and Flier, J.S. (2006).
TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin.
Invest. 116, 3015–3025.
Singh, R., and Cuervo, A.M. (2012). Lipophagy: connecting autophagy and
lipid metabolism. Int. J. Cell Biol. 2012, 282041.
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K.,
Cuervo, A.M., and Czaja, M.J. (2009a). Autophagy regulates lipid metabolism.
Nature 458, 1131–1135.
Singh, R., Xiang, Y., Wang, Y., Baikati, K., Cuervo, A.M., Luu, Y.K., Tang, Y.,
Pessin, J.E., Schwartz, G.J., and Czaja, M.J. (2009b). Autophagy regulates
adipose mass and differentiation in mice. J. Clin. Invest. 119, 3329–3339.
Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai,
S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., et al. (2007). Role of the
Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced
inflammatory changes in the interaction between adipocytes and macro-
phages. Arterioscler. Thromb. Vasc. Biol. 27, 84–91.
Talukdar, S., Oh, Y., Bandyopadhyay, G., Li, D., Xu, J., McNelis, J., Lu, M., Li,
P., Yan, Q., Zhu, Y., et al. (2012). Neutrophils mediate insulin resistance inmice
fed a high-fat diet through secreted elastase. Nat. Med. 18, 1407–1412.
Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and
Ferrante, A.W., Jr. (2003). Obesity is associated with macrophage accumula-
tion in adipose tissue. J. Clin. Invest. 112, 1796–1808.
Winer, D.A., Winer, S., Shen, L., Wadia, P.P., Yantha, J., Paltser, G., Tsui, H.,
Wu, P., Davidson, M.G., Alonso, M.N., et al. (2011). B cells promote insulin
resistance through modulation of T cells and production of pathogenic IgG
antibodies. Nat. Med. 17, 610–617.
Wu, H., Ghosh, S., Perrard, X.D., Feng, L., Garcia, G.E., Perrard, J.L.,
Sweeney, J.F., Peterson, L.E., Chan, L., Smith, C.W., and Ballantyne, C.M.
(2007). T-cell accumulation and regulated on activation, normal T cell ex-
pressed and secreted upregulation in adipose tissue in obesity. Circulation
115, 1029–1038.
Wu, D., Molofsky, A.B., Liang, H.E., Ricardo-Gonzalez, R.R., Jouihan, H.A.,
Bando, J.K., Chawla, A., and Locksley, R.M. (2011). Eosinophils sustain adi-
pose alternatively activatedmacrophages associated with glucose homeosta-
sis. Science 332, 243–247.
Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols,
A., Ross, J.S., Tartaglia, L.A., and Chen, H. (2003). Chronic inflammation in fat
plays a crucial role in the development of obesity-related insulin resistance.
J. Clin. Invest. 112, 1821–1830.
Zhang, Y., Goldman, S., Baerga, R., Zhao, Y., Komatsu, M., and Jin, S. (2009).
Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a
role in adipogenesis. Proc. Natl. Acad. Sci. USA 106, 19860–19865.Inc.
